Diabetes care product company ARKRAY USA Inc reported on Monday the launch of newest blood glucose monitoring system (BGMS) in the US, the GLUCOCARD Shine XL.
According to the company, the GLUCOCARD Shine XL blood glucose monitoring system is now available for order in the US.
Highly accurate with a large LED screen intended to facilitate quick and easy viewing of blood glucose test results, the GLUCOCARD Shine XL BGMS offers an ergonomically designed meter that provides a secure grip during testing as well as uses the same test strips as the prior GLUCOCARD Shine, which has been proven to provide highly accurate test results in an easy to use form.
ARKRAY USA Inc, which is a division of ARKRAY headquartered in Kyoto, Japan, currently does business in more than 80 countries worldwide and is the market leader in diabetes management in the long-term care market in the US.
Kodiak Sciences reports positive Phase 3 results for Zenkuda in diabetic retinopathy
Maze Therapeutics reports positive Phase 2 data for MZE829 in patients with AMKD
Andel launches new direct-to-employer medication platform for GLP-1s
Dexcom highlights new diabetes outcomes and product roadmap at ATTD 2026
Cedar Health Research opens new embedded research site within Texas Native Health
AstraZeneca agrees obesity and type 2 diabetes collaboration with CSPC
Alvotech reaches global settlement over aflibercept biosimilar patents
MedPal AI announces approval to supply Eli Lilly medicines in UK
Hanmi Pharmaceutical signs distribution agreement with Laboratorios Sanfer in Mexico
Viking Therapeutics publishes Phase 2 data showing up to 14.7% weight loss with VK2735